THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

associated device failures mainly because neither medical professionals nor shoppers have all of the information needed to make adequate judgments of products good quality and authorized tort therapies are gradual, inefficient, and extremely expensive. The improvements towards the CGMP regulation will require manufacturers to increase [Page 52644]